AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 114 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $22,000 | -15.4% | 46,250 | 0.0% | 0.00% | – |
| Q4 2021 | $26,000 | -66.2% | 46,250 | 0.0% | 0.00% | – |
| Q3 2021 | $77,000 | +413.3% | 46,250 | +68.5% | 0.00% | – |
| Q1 2019 | $15,000 | +36.4% | 27,440 | 0.0% | 0.00% | – |
| Q4 2018 | $11,000 | -21.4% | 27,440 | 0.0% | 0.00% | – |
| Q3 2018 | $14,000 | -76.7% | 27,440 | 0.0% | 0.00% | – |
| Q2 2018 | $60,000 | -59.2% | 27,440 | +41.0% | 0.00% | -100.0% |
| Q1 2015 | $147,000 | +119.4% | 19,457 | 0.0% | 0.00% | – |
| Q4 2014 | $67,000 | -2.9% | 19,457 | 0.0% | 0.00% | – |
| Q3 2014 | $69,000 | -57.4% | 19,457 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $162,000 | +82.0% | 19,457 | +38.8% | 0.00% | – |
| Q1 2014 | $89,000 | -11.0% | 14,018 | 0.0% | 0.00% | – |
| Q4 2013 | $100,000 | -4.8% | 14,018 | 0.0% | 0.00% | – |
| Q3 2013 | $105,000 | +29.6% | 14,018 | 0.0% | 0.00% | – |
| Q2 2013 | $81,000 | – | 14,018 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 291,500 | $137,000 | 0.14% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $441,000 | 0.14% |
| CVA Family Office, LLC | 1,137,920 | $535,000 | 0.13% |
| Cypress Capital Management LLC (WY) | 179,525 | $84,000 | 0.10% |
| Willis Investment Counsel | 2,075,840 | $976,000 | 0.05% |
| NTB Financial Corp | 146,100 | $69,000 | 0.05% |
| SRS Capital Advisors, Inc. | 629,172 | $296,000 | 0.04% |
| Helen Stephens Group, LLC | 117,222 | $55,000 | 0.04% |
| COURIER CAPITAL LLC | 464,356 | $218,000 | 0.02% |
| Western Wealth Management, LLC | 946,800 | $444,000 | 0.02% |